华纳药厂：产品“富马酸福莫特罗吸入溶液”取得注册证

Group 1 - Warner Pharmaceuticals has received approval from the National Medical Products Administration for the drug registration certificate of Formoterol Fumarate Inhalation Solution [1] - The company's revenue composition for the year 2024 is projected to be 99.01% from pharmaceutical manufacturing and 0.99% from other businesses [1] - As of the report, Warner Pharmaceuticals has a market capitalization of 6.4 billion yuan [1]